113 related articles for article (PubMed ID: 32665185)
1. Outcomes of Treatment for HIV-Infected Lymphoma Patients: A National Cancer Database (NCDB) Analysis.
Jayakrishnan TT; Bakalov V; Samhouri Y; Wegner RE; Sadashiv S
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e864-e870. PubMed ID: 32665185
[TBL] [Abstract][Full Text] [Related]
2. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
3. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.
Farina L; Bruno B; Patriarca F; Spina F; Sorasio R; Morelli M; Fanin R; Boccadoro M; Corradini P
Leukemia; 2009 Jun; 23(6):1131-8. PubMed ID: 19194465
[TBL] [Abstract][Full Text] [Related]
4. Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
Epperla N; Hamadani M; Ahn KW; He F; Kodali D; Kleman A; Hari PN; Pasquini M; Fenske TS; Craig MD; Kanate AS; Bachanova V
Biol Blood Marrow Transplant; 2018 May; 24(5):983-988. PubMed ID: 29410340
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.
Kyvernitakis A; Mahale P; Popat UR; Jiang Y; Hosry J; Champlin RE; Torres HA
Biol Blood Marrow Transplant; 2016 Apr; 22(4):717-722. PubMed ID: 26712592
[TBL] [Abstract][Full Text] [Related]
6. High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion Lymphoma.
Mirza AS; Dholaria BR; Hussaini M; Mushtaq S; Horna P; Ravindran A; Kumar A; Ayala E; Kharfan-Dabaja MA; Bello C; Chavez JC; Sokol L
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e513-e520. PubMed ID: 31253594
[TBL] [Abstract][Full Text] [Related]
7. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Barta SK; Samuel MS; Xue X; Wang D; Lee JY; Mounier N; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Little RF; Dunleavy K; Wilson WH; Wyen C; Remick SC; Kaplan LD; Ratner L; Noy A; Sparano JA
Ann Oncol; 2015 May; 26(5):958-966. PubMed ID: 25632071
[TBL] [Abstract][Full Text] [Related]
8. Risk, Outcomes, and Predictors of
Bhandari S; Pandey RK; Dahal S; Shahreyar M; Dhakal B; Jha P; Venkatesan T; Saeian K
South Med J; 2018 Oct; 111(10):628-633. PubMed ID: 30285271
[TBL] [Abstract][Full Text] [Related]
9. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data.
Yoshinaga N; Kanda J; Aisa Y; Hagiwara S; Mori T; Fukuda T; Ishida Y; Hashimoto H; Iwato K; Kanda Y; Kurokawa M; Nakazawa H; Ota S; Uchida N; Ichinohe T; Atsuta Y; Takaori-Kondo A
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1596-1601. PubMed ID: 29551446
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography.
Marani C; Raiola AM; Morbelli S; Dominietto A; Ferrarazzo G; Avenoso D; Giannoni L; Varaldo R; Gualandi F; Grazia D; Lamparelli T; Bregante S; Van Lint MT; Ibatici A; Bovis F; Lemoli RM; Gobbi M; Bacigalupo A; Angelucci E
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2501-2508. PubMed ID: 30041010
[TBL] [Abstract][Full Text] [Related]
11. Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.
Wudhikarn K; Brunstein CG; Bachanova V; Burns LJ; Cao Q; Weisdorf DJ
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1497-504. PubMed ID: 21338707
[TBL] [Abstract][Full Text] [Related]
12. Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.
Ram R; Gooley TA; Maloney DG; Press OW; Pagel JM; Petersdorf SH; Shustov AR; Flowers ME; O'Donnell P; Sandmaier BM; Storb RF; Gopal AK
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1537-45. PubMed ID: 21536145
[TBL] [Abstract][Full Text] [Related]
13. Role of Allogeneic HCT as Postremission Therapy for Transplant-Eligible Adult Lymphoblastic Leukemia/Lymphoma After Frontline Hyper-CVAD.
Damlaj M; Snnallah M; Bashir R; Eddine IS; Alahmari B; Salama H; Alaskar A; Alhejazi A; Alzahrani M
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):690-696. PubMed ID: 32636149
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
[TBL] [Abstract][Full Text] [Related]
15. The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection.
Ambinder RF
Bone Marrow Transplant; 2009 Jul; 44(1):1-5. PubMed ID: 19448679
[TBL] [Abstract][Full Text] [Related]
16. Survival among patients with primary central nervous system lymphoma, 1973-2004.
Norden AD; Drappatz J; Wen PY; Claus EB
J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
[TBL] [Abstract][Full Text] [Related]
18. Stem cell transplantation for lymphoma patients with HIV infection.
Michieli M; Mazzucato M; Tirelli U; De Paoli P
Cell Transplant; 2011; 20(3):351-70. PubMed ID: 20875226
[TBL] [Abstract][Full Text] [Related]
19. Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
Bachanova V; Burns LJ; Ahn KW; Laport GG; Akpek G; Kharfan-Dabaja MA; Nishihori T; Agura E; Armand P; Jaglowski SM; Cairo MS; Cashen AF; Cohen JB; D'Souza A; Freytes CO; Gale RP; Ganguly S; Ghosh N; Holmberg LA; Inwards DJ; Kanate AS; Lazarus HM; Malone AK; Munker R; Mussetti A; Norkin M; Prestidge TD; Rowe JM; Satwani P; Siddiqi T; Stiff PJ; William BM; Wirk B; Maloney DG; Smith SM; Sureda AM; Carreras J; Hamadani M;
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1605-11. PubMed ID: 25983043
[TBL] [Abstract][Full Text] [Related]
20. Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
Hamadani M; Khanal M; Ahn KW; Litovich C; Chow VA; Eghtedar A; Karmali R; Winter A; Fenske TS; Sauter C; Kharfan-Dabaja MA; Awan FT
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1099-1105. PubMed ID: 32165327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
